Startseite Crystal structure of chlorido-(η6-p-cymene)-(N-(2-fluorophenyl)-1-(pyridin-2-yl)methanimine-κ2N,N′)ruthenium(II) – acetone (1/1), C22H23ClN2F7OPRu
Artikel Open Access

Crystal structure of chlorido-(η6-p-cymene)-(N-(2-fluorophenyl)-1-(pyridin-2-yl)methanimine-κ2N,N′)ruthenium(II) – acetone (1/1), C22H23ClN2F7OPRu

  • Joel M. Gichumbi , Bernard Omondi ORCID logo EMAIL logo und Holger B. Friedrich
Veröffentlicht/Copyright: 25. Januar 2020

Abstract

C22H23ClN2F7OPRu, monoclinic, P21/c (no. 14), a = 7.30480(10) Å, b = 12.9540(3) Å, c = 28.7076(6) Å, β = 96.6990(10)°, V = 2697.95(9) Å3, Z = 4, Rgt(F) = 0.0196, wRref(F2) = 0.0479, T = 100(2) K.

CCDC no.: 1967151

The molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Red block
Size:0.26 × 0.23 × 0.22 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:0.81 mm−1
Diffractometer, scan mode:Bruker Smart Apex-II, φ and ω
θmax, completeness:28.3°, >99%
N(hkl)measured, N(hkl)unique, Rint:101207, 6690, 0.020
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 6475
N(param)refined:346
Programs:Bruker [1], SHELX [2], WinGX/ORTEP [3]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
C230.1629(3)0.3209(2)0.44231(7)0.0428(5)
H23A0.28090.28710.43920.064*
H23B0.17880.39600.44170.064*
H23C0.07180.29990.41620.064*
C240.0973(2)0.28990(13)0.48774(6)0.0255(3)
C25−0.0875(2)0.33045(16)0.49642(6)0.0326(4)
H25A−0.18400.29370.47640.049*
H25B−0.09450.40430.48910.049*
H25C−0.10490.31990.52940.049*
O10.1869(2)0.23504(12)0.51589(5)0.0443(4)
C10.96435(18)0.17810(10)0.72779(5)0.0135(2)
C20.97641(19)0.09853(11)0.76040(5)0.0164(3)
C31.06889(19)0.10925(12)0.80501(5)0.0189(3)
H31.07340.05410.82690.023*
C41.1548(2)0.20259(12)0.81690(5)0.0204(3)
H41.22200.21110.84700.024*
C51.1435(2)0.28396(12)0.78505(5)0.0199(3)
H51.20240.34770.79360.024*
C61.04645(19)0.27232(11)0.74080(5)0.0162(3)
H61.03610.32860.71940.019*
C70.91593(18)0.09242(11)0.65526(5)0.0162(3)
H71.00730.04340.66650.019*
C80.82373(18)0.08754(11)0.60784(5)0.0152(2)
C90.60555(19)0.16595(11)0.55441(5)0.0174(3)
H90.51390.21730.54710.021*
C100.6446(2)0.09750(12)0.51947(5)0.0215(3)
H100.58100.10290.48880.026*
C110.7762(2)0.02170(12)0.52974(5)0.0232(3)
H110.8036−0.02590.50630.028*
C120.8677(2)0.01627(12)0.57480(5)0.0213(3)
H120.9586−0.03520.58290.026*
C130.45898(18)0.39326(10)0.64335(5)0.0138(2)
C140.36734(18)0.30125(11)0.62899(5)0.0145(2)
H140.29780.29770.59890.017*
C150.37743(18)0.21297(11)0.65902(5)0.0149(2)
H150.31870.15060.64810.018*
C160.47334(19)0.21686(11)0.70469(5)0.0152(3)
C170.56286(19)0.31154(11)0.71980(5)0.0153(3)
H170.62640.31660.75050.018*
C180.55750(18)0.39651(10)0.68971(5)0.0146(2)
H180.62050.45790.70010.017*
C190.45954(19)0.48809(11)0.61267(5)0.0160(3)
H190.57730.52600.62200.019*
C200.4495(2)0.46452(12)0.56042(5)0.0253(3)
H20A0.45050.52930.54280.038*
H20B0.55600.42250.55450.038*
H20C0.33570.42660.55030.038*
C210.3006(2)0.55837(11)0.62313(5)0.0221(3)
H21A0.29890.62040.60350.033*
H21B0.18350.52140.61630.033*
H21C0.31770.57840.65630.033*
C220.4856(2)0.12441(11)0.73640(5)0.0197(3)
H22A0.37300.11920.75180.030*
H22B0.59230.13170.76030.030*
H22C0.49960.06190.71790.030*
F10.89194(13)0.00775(7)0.74847(3)0.02501(19)
F20.49083(18)0.82957(10)0.59316(4)0.0432(3)
F30.19196(16)0.83020(8)0.60659(4)0.0407(3)
F40.33518(16)0.98103(8)0.59499(4)0.0376(3)
F50.55918(13)0.94162(8)0.65351(4)0.0299(2)
F60.26128(14)0.94113(8)0.66716(4)0.0333(2)
F70.41625(14)0.79047(7)0.66533(3)0.0264(2)
P30.37645(5)0.88512(3)0.63004(2)0.01883(8)
Cl20.89479(4)0.36426(3)0.62383(2)0.01570(6)
Ru10.65734(2)0.26281(2)0.65280(2)0.01010(3)
N10.86875(15)0.16607(9)0.68160(4)0.0128(2)
N20.69313(15)0.16166(9)0.59806(4)0.0136(2)

Source of material

To a suspension of [(η6-p-cymene)Ru(μ-Cl)I]2 (0.2 mmol) in methanol (20 mL) was added the organic ligand (N-(2-fluorophenyl)-1-(pyridin-2-yl)methanimine; 0.42 mmol). The mixture was stirred at room temperature for 3 hours followed by the reduction in the volume of the solvent in vacuo to about (10 mL) before adding NH4PF6 (0.42 mmol). The mixture was then cooled in an ice bath while stirring for 2 hours leading to a precipitate, which was collected by filtration. The filtrate was washed with diethyl ether and dried in vacuo. Crystals were grown by the liquid diffusion method in which the solutions of the compounds in acetone were layered with hexane and left undisturbed for 2 days.

Orange, yield 85%, m.p. 150 °C (decomp.). 1H NMR (400 MHZ, DMSO-d6): δ [ppm] 9.58 (d, JHH = 5.4 Hz, 1H, Py); 8.90 (s, 1H, CH=N); 8.35 (M, 1H, Py); 8.28 (m, 1H, Py); 7.90 (m, 3H, Py); 7.51(t, 2H, p-cyAr); 6.18 (d, JHH = 6.10 Hz, 1H(p-cyAr)); 5.94 (d, JHH = 6.10 Hz, 1H, (p-cyAr)); 2.57 (sep, 1H, CH) 2.63 (m, 1H, CH (Me)2); 2.16 (s, 3H, (Me)); 1.01 (d, JHH = 6.64 Hz, 3H, (Me) (0. 95 (d, JHH = 6.88 Hz, 3H, (Me). 13C NMR (400 MHZ, DMSO-d6): δ [ppm] 168.07 (CH=N), 159.9 (Py), 155.5 (Py); 148.12 (Py); 139.94 (Py); 130.10 (py); 128.2 (Py); 124.80 (Ar); 124.70 (Ar); 116.60 (Ar); 105.2 (Ar); 103.4 (Ar); 86.6 (Ar); 86.1 (Ar); 85.0 (Ar); 84.8 (Ar); 30.5 (Me); 21.8 (Me); 18.4 (Me). IR (solid state): γ (C=N) 1610.1 cm−1. MS (ESI, M/Z): 471.0580 [C19H26ClN2Ru]+.

Experimental details

Crystal evaluation and data collection were done on a Bruker Smart APEX2 diffractometer with an Oxford Cryostream low temperature apparatus operating at 100(1) K. The structure was solved by the direct method using the SHELXS [2] program and refined. All hydrogen atoms were placed in idealized positions and refined in riding models with Uiso assigned the values of 1.2 times those of their parent atoms and the distances of C—H were constrained to 0.93 Å for all the aromatic H atoms, 0.96 Å for methyl hydrogens and 0.98 Å for methine hydrogen. The visual crystal structure information was performed using ORTEP-3 [3].

Comment

Arene ruthenium half-sandwich compounds belong to a well established family of robust organometallic complexes [4], [5], [6], [7], [8], [9]. There is a continued interest in arene ruthenium systems due to their potential as catalysts in a wide range of organic reactions [4], [5], [6], [7], [8], [9], promising anticancer and antimicrobial properties [10], [11] and their DNA binding ability [12]. This contribution is a part of our continuing interest in half-sandwich ruthenium(II) complexes with N,N′-bidentate ligands [5], [6], [7], [8], [9], [10], [11], [12].

In the asymmetric unit there is one cationic ruthenium complex featuring the “pseudo-octahedral three-legged piano stool” structures, one hexafluorophosphate anion and an acetone solvent molecule. The ruthenium centre is coordinated to the N,N′-bidentate ligand through the N atom of the pyridine and the N atom of the imine bond and a chlorido ligand at the base of the stool and the p-cymene ring at the apex of the stool [5], [6], [7], [8], [9], [10], [11], [12]. The Ru—N bond lengths of the complex are 2.0835(14) and 2.0858(14) Å and these value are comparable to those reported for other arene ruthenium complexes with N,N′ donor ligands [5], [6], [7], [8], [9], [10], [11], [12]. The N—Ru—N bond angle is 76.63(4)°. The N—Ru—Cl bond angles are 86.26(3) and 85.63(3)°. These values are in agreement to those reported for related compounds [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16].

Acknowledgements

We wish to extend our sincere thanks to the NRF, THRIP (Grant no. Tp 1208035643) and UKZN (URF) for financial support. Gichumbi, M. Joel thanks Prof. E. N. Njoka for his support.

References

1. Bruker-AXS. Bruker-AXS. Madison, WI, USA (2009).Suche in Google Scholar

2. Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Suche in Google Scholar PubMed

3. Farrugia, L. J.: WinGX and ORTEP for Windows. J. Appl. Crystallogr. 45 (2012) 849–854.10.1107/S0021889812029111Suche in Google Scholar

4. Gichumbi, J. M.; Friedrich, H. B.: Half-sandwich complexes of platinum complexes of platinum group metals (Ir,Rh, Ru and Os) and some recent biological and catalytic applications. J. Organomet. Chem. 866 (2018) 123–143.10.1016/j.jorganchem.2018.04.021Suche in Google Scholar

5. Gichumbi, J. M.; Friedrich, H. B.; Omondi, B.: Synthesis and characterization of piano-stool ruthenium complexes with N,N′-pyridine imine bidentate ligands and their application in styrene oxidation. J. Organomet. Chem. 808 (2016) 87–96.10.1016/j.jorganchem.2016.02.015Suche in Google Scholar

6. Gichumbi, J. M.; Friedrich, H. B.; Omondi, B.: Application of arene ruthenium(II) complexes with pyridine-2-carboxaldimine ligands in the transfer hydrogenation of ketones. J. Mol. Catal. A: Chem. 416 (2016) 29–38.10.1016/j.molcata.2016.02.012Suche in Google Scholar

7. Gichumbi, J. M.; Friedrich, H. B.; Omondi, B.: Synthesis and characterization of water-soluble arene-ruthenium complexes and their application in biphasic olefin oxidation. J. Coord. Chem. 416 (2018) 1–13.10.1080/00958972.2018.1548702Suche in Google Scholar

8. Gichumbi, J. M.; Friedrich, H. B.; Omondi, B.: Synthesis and characterization of half-sandwich ruthenium(II) complexes with N-alkyl pyridyl-imine ligands and their application in transfer hydrogenation of ketones. Transition Met. Chem. 41 (2016) 867–877.10.1007/s11243-016-0089-5Suche in Google Scholar

9. Gichumbi, J. M.; Friedrich, H. B.; Omondi, B.: Synthesis and characterization of some new half-sandwich ruthenium(II) complexes with bidentate N,N-ligands and their application in alcohol oxidation. Inorg. Chim. Acta 456 (2017) 55–63.10.1016/j.ica.2016.11.014Suche in Google Scholar

10. Gichumbi, J. M.; Omondi, B.; Lazarus, G.; Singh, M.; Shaikh, N.; Chenia, H. Y.; Friedrich, H. B.: Influence of halogen substitution in the ligand sphere on the antitumor and antibacterial activity of half-sandwich ruthenium(II) complexes [RuX(η6–arene)(C5H4N–2–CH = N–Ar)]+. Z. Anorg. Allg. Chem. 643 (2017) 699–711.10.1002/zaac.201600427Suche in Google Scholar

11. Gichumbi, J. M.; Friedrich, H. B.; Omondi, B.; Singh, M.; Naicker, K.; Chenia, H. Y.: Synthesis, characterization, cytotoxic and antimicrobial activity of ruthenium(II) arene complexes with N,N-bidentate ligands. J. Coord. Chem. 69 (2016) 3531–3544.10.1080/00958972.2016.1243238Suche in Google Scholar

12. Thangavel, S.; Rajamanikandan, R.; Friedrich, H. B.; Ilanchelian, M.; Omondi, B.: Binding interaction, conformational change, and molecular docking study of N-(pyridin-2-ylmethylene)aniline derivatives and carbazole Ru(II) complexes with human serum albumins. Polyhedron 107 (2016) 124–135.10.1016/j.poly.2016.01.017Suche in Google Scholar

13. Nyawade, E. A.; Friedrich, H. B.; Omondi, B.; Mpungose, P.: Synthesis and characterization of new (η5-cyclopentadienyl)dicarbonylruthenium(II) amine complexes: their application as homogeneous catalysts in styrene oxidation. Organometallics 34 (2015) 4922–4931.10.1021/acs.organomet.5b00564Suche in Google Scholar

14. Chow, M.; Licona, C.; Yuan Qian Wong, D.; Pastorin, G.; Gaiddon, C.; Ang, W. H.: Discovery and investigation of anticancer ruthenium–arene Schiff-base complexes via water-promoted combinatorial three-component assembly. J. Med. Chem. 57 (2014) 6043–6442.10.1021/jm500455pSuche in Google Scholar PubMed

15. Gichumbi Joel, M.; Omondi, B.; Friedrich Holger, B.: Crystal structure of chlorido-(N-(2,5-dichlorophenyl)-1-(pyridin-2-yl)methanimine-κ2N,N′)(η6-1-isopropyl-4-methylbenzene)ruthenium (II) tetrafluoroborate, C22H22Cl3N2BF4Ru. Z. Kristallogr. NCS 232 (2017) 309–311.10.1515/ncrs-2016-0254Suche in Google Scholar

16. Gichumbi Joel, M.; Friedrich Holger, B.; Omondi, B.: Crystal structure of chlorido-(η6–1-isopropyl-4-methyl benzene)-(1-(pyridin-2-yl)-N-(p-tolyl)methanimine-κ2N,N′)ruthenium(II) hexafluorophosphate(V), C23H26ClF6N2PRu. Z. Kristallogr. NCS 232 (2017) 285–287.10.1515/ncrs-2016-0241Suche in Google Scholar

Received: 2019-10-25
Accepted: 2019-11-21
Published Online: 2020-01-25
Published in Print: 2020-04-28

©2020 Joel M. Gichumbi et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 Public License.

Artikel in diesem Heft

  1. Frontmatter
  2. Crystal structure of catena-poly[(μ2-3-(benzo[d]thiazol-2-yl)-5-carboxybenzoato-κ2N:O)silver(I)], C15H8AgNO4S
  3. Crystal structure of bis(4-phenylpiperazin-1-ium) bis(2-(4-phenylpiperazin-1-yl)succinato-κ2O,O′)copper(II) tetrahydrate, C48H70CuN8O12, [C10H14N2]2[Cu(C14H17N2O4)2] ⋅ 4 H2O
  4. Crystal structure of triaqua-bis(2-(6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenedecahydronaphthalen-1-yl)-1-(2-oxo-2,5-dihydrofuran-3-yl)ethane-1-sulfonato-κ2O,O′)calcium(II) – ethanol (1/2), C44H76CaO19S2
  5. The crystal structure of ethyl 5-(4-(diphenylamino)phenyl)thiophene-2-carboxylate, C25H21NO2S
  6. The crystal structure of 5-bromo-2-(2-methyl-2H-tetrazol-5-yl)pyridine, C7H6BrN5
  7. The crystal structure of (E)-5-chloro-2-hydroxy-N′-(2-hydroxy-4-methoxybenzylidene)benzohydrazide, C15H13ClN2O4
  8. The crystal structure of (2Z,2′Z)-N′,N′′′′-(pyridine-2,6-dicarbonyl)dipicolinohydrazonamide, C19H17N9O2
  9. Photochromic properties and crystal structure of 3,3′-(perfluorocyclopent-1-ene-1,2-diyl)bis(5-(4-(azidomethyl)phenyl)-2-methylthiophene), C29H20F6N6S2
  10. Crystal structure of aqua-dichlorido-(4-(((3-ethoxy-2-oxidobenzylidene)hydrazono)(oxido)methyl)pyridin-1-ium-κ3N,O,O′)iron(III), C15H16Cl2N3O4Fe
  11. Crystal structure of catena-poly[diaqua-(μ2-4,4′-bipyridine-κ2N:N′)-bis(2,3,4,5-tetrabromo-6-carboxybenzoato-κ1O)-nickel(II)], C26H14Br8NiN2O10
  12. Crystal structure of diethanol-κ1O-bis(μ2-N-((2-oxidonaphthalen-1-yl)methylene)pyrazine-2-carbohydrazonato-κ5N,O,O′:O′:N′)-bis(nitrato-κ2O,O′)dieuropium(III), C36H32N10O12Eu2
  13. The crystal structure of 2-aminoisophthalic acid, C8H7NO4
  14. Crystal structure of (E)-2-(4-((3,4-difluorobenzyl)oxy)styryl)-4,6-dimethoxybenzaldehyde, C24H20F2O4
  15. Crystal structure of 2-benzoylpyrene, C23H14O
  16. Crystal structure of chlorido-(η6-p-cymene)-(N-(2-fluorophenyl)-1-(pyridin-2-yl)methanimine-κ2N,N′)ruthenium(II) – acetone (1/1), C22H23ClN2F7OPRu
  17. The crystal structure of 2-bromoisonicotinic acid, C6H4BrNO2
  18. Crystal structure of 1,3,5,7-tetraphenyl-8-(N-phenylformamido)-2-oxa-5-azabicyclo[4.2.0]oct -3-en-7-yl benzoate, C44H34N2O4
  19. Synthesis and crystal structure of 4-(3-acetyl-5-(thiophen-2-yl)-2,3-dihydro-1,3,4-oxadiazol-2-yl)-7-(diethylamino)-2H-chromen-2-one, C21H21N3O4S
  20. Crystal structure of poly[diaqua-(μ2-4,4′-bipyridine-κ2N:N′)-(μ2-3,4,5,6-tetrafluorophthalato-κ2O:O′)nickel(II)], C18H12F4NiN2O6
  21. Crystal structure of 4-hydroxynaphtho[2,3-b]benzofuran-6,11-dione, C16H8O4
  22. The crystal structure of 3,10-bis(4-methoxyphenyl)-6,12-dibenzyl-2,9-acetyl-6,12-diazapentacyclo[6.3.1.02,7.04,11.05,9]dodecane – acetone (1/1), C45H48N2O5
  23. The crystal structure of (E)-2-(((2-(1H-indol-3-yl)ethyl)iminio)methyl)-6-bromophenolate, C17H15N2BrO
  24. Crystal structure of catena-poly[diaqua-(μ2-oxalyl dihydrazide-κ4N,O:N′,O′)-bis(μ2-pyridine-2,3-dicarboxylato-κ3N,O,O′)dicadmium(II)] hexahydrate, C16H28O18N6Cd2
  25. Crystal structure of poly[tetra-(μ4-naphthalene-1,8-dicarboxylato-κ4O:O,O′: O′′:O′′,O′′′)-(μ4-oxo-κ4O:O:O:O) penta-lead(II)], C48H24O17Pb5
  26. Crystal structure of 5H-dibenzo[c,f][1,5]oxabismocin-12 (7H)-yl acetate, C16H15O3Bi
  27. The crystal structure of 2-(4-chloro-6-nitrophenyl)-1-(4-chloro-3-nitrophenyl)diazene 1-oxide, C12H6Cl2N4O5
  28. Crystal structure of bis(3-methyl-N-(1-(pyrazin-2-yl)ethylidene)benzohydrazonato-κ3O,N,N′)nickel(II), C28H26N8O2Ni
  29. Crystal structure of 3,10-bis(4-chlorophenyl)-6,12-dibenzyl-2,9-acetyl-6,12-diazapentacyclo[6.3.1.02,7.04,11.05,9]-dodecane, C40H36Cl2N2O2
  30. Crystal structure of bis[(μ2-4⋯O,O′:O′)-(4-hydroxybenzoato-κ2O,O′)-(1,10-phenanthroline-κ2N,N′)]-di-lead(II)μ-4-hydroxybenzoato-κ3O,O′:O′3O,O′:O′-bis-[(4-hydroxybenzoato-κ2O,O′)bis(1,10-phenanthroline-κ2N,N′)di-lead(II)] monohydrate, C52H36N4O12Pb2 ⋅ H2O
  31. Crystal structure of poly[diaqua-(μ3-3,4,5,6-tetrafluoro-phthalato-κ3O:O′:O′′)-(μ2-1,2-bis(4-pyridyl)ethene-κ2N:N′)cobalt(II)], C14H9CoF4NO6
  32. Crystal structure of 7-hydroxy-4-phenyl-2H-chromen-2-one, C15H10O3
  33. Crystal structure of 3,7-dimethyl-1-(5-oxohexyl)-3,7-dihydro-1H-purine-2,6-dione 4-hydroxybenzoic acid, C20H24N4O6
  34. Crystal structure of catena-poly[(μ2-1,5-dimethyl-2-phenyl-4-((pyridin-4-ylmethylene)amino)-1,2-dihydro-3H-pyrazol-3-one-κ2N:O)-bis(nitrato-κ1O)zinc(II)], C17H16N6O7Zn
  35. The crystal structure of diaqua-bis(6-aminopicolinato-κ2N,O)magnesium(II), C12H14O6N4Mg
  36. Crystal structure of (pyridine-2-carboxamide-κ2N,O)-[tris((1H-benzo[d]imidazol-2-yl)methyl)amine-κ4N,N′,N′′,N′′′]nickel(II) diperchlorate — methanol (1/3), C33H39Cl2N9NiO12
  37. Crystal structure of catena-poly[diaqua-bis(3-(4-trifluoromethyl-phenyl)-acrylato-κO1)-(μ2-1,4-bis(1-imidazolyl)benzene-κ2N3:N3)cobalt(II)], C32H26CoF6N4O6
  38. Crystal structure of (E)-3-(2-(2-hydroxy-4-methoxystyryl)-3,3-dimethyl-3H-indol-1-ium-1-yl)propane-1-sulfonate monohydrate, C22H25NO5S⋅H2O
  39. The crystal structure of bis(N-oxy-2-(1H-tetrazol-1-yl) acetamide κ2O,O′)-diaqua-zinc(II), C6H12ZnN10O6
  40. Crystal structure of (E)-4-((4-chlorophenylimino)methyl)pyridinium 3,5-dinitrobenzoate, C19H13ClN4O6
  41. Crystal structure of dichlorido-bis((E)-2-((pyridin-4-ylmethylene)amino)phenol)zinc(II), C24H20Cl2N4O2Zn
  42. Crystal structure of cyclo-[tetrachlorido-bis(μ2-p-xylylenediamine-κ2N:N′)dipalladium(II)] dimethyl sulfoxide solvate, C20H36Cl4N4O2Pd2S2
  43. Crystal structure of 4-(3-fluorophenyl)-7-hydroxy-2H-chromen-2-one, C15H9FO3
  44. Crystal structure of (E)-2-((2-(pyrimidin-2-yl)hydrazono)methyl)quinolin-1-ium perchlorate – methanol (1/1), C15H16N5O5Cl
  45. The crystal structure of bis(N-(amino(pyridin-2-yl)methylene)-5-chloro-2-hydroxybenzohydrazonato-κ3N,N′,O)zinc(II) – methanol (2/5), C57H60Cl2N16O13Zn2
  46. Synthesis and crystal structure of 4,4′-di(4-pyridyl)-6,6′-di(tert-butyl)-2,2′-[propylenedioxybis(nitrilomethylidyne)]diphenol, C35H40N4O4
  47. Crystal structure of (3E,3′E)-3,3′-((1,3,4-thiadiazole-2,5-diyl)bis(sulfanediyl))bis(4-hydroxy-4-phenylbut-3-en-2-one), C22H18N2O4S3
  48. Crystal structure of (N-benzyl-N-methyl-dithiocarbamato-κ2S,S′)di(4-chlorobenzyl)chloridotin(IV), C23H22Cl3NS2Sn
  49. Crystal structure of (1,4,7,10,13,16-hexaoxacyclooctadecane-κ6O6) sodium bromide hydrate, [Na(18-crown-6)]Br ⋅ H2O, C12H26BrNaO7
  50. Crystal structure of 7-ethoxyl-6,8-difluoro-4-oxo-1-phenyl-1,4-dihydro-quinoline-3-carboxylic acid, C18H13F2N1O4
  51. Crystal structure of chlorido (2-(4-ethylphenyl)pyrimidine-k2C,N)(triphenylphosphane-kP) palladium(II), C30H26ClN2PPd
  52. Crystal structure of 18-crown-6 – 1,4-diiodotetrafluorobenzene – acetonitrile (1/1/2), C22H30F4I2N2O6
  53. Crystal structure of diisobutyl 2,5-dihydroxycyclohexa-1,4-diene-1,4-dicarboxylate, C16H24O6
  54. Crystal structure of poly[[tris(μ2-cis-1,2-cyclohexanedicarboxylato)-κ2O, O′]-bis[μ3-1,3,5-tris[(1H-imidazol-1-yl)methyl]benzene-κ3N, N′,N′′]-trizinc(II)] – water (1/20), C60H106N12O32Zn3
  55. The synthesis and crystal structure of 5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-4-((trifluoromethyl)sulfinyl)-1H-pyrazole-3-carboxamide–tetrahydrofuran (1/1), C16H14N4Cl2F6O3S
  56. Crystal structure of dimethylbis(diisopropyldithiocarbamato-κ2S,S′)tin(IV), C16H34N2S4Sn
  57. Crystal structure of diisopropyl 2,5-dihydroxycyclohexa-1,4-diene-1,4-dicarboxylate, C14H20O6
  58. The synthesis and crystal structure of ethyl (E)-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-5-((2-methoxybenzylidene)amino)-4-((trifluoromethyl)sulfinyl)-1H-pyrazole-3-carboxylate, C22H15N3Cl2F6O4S
  59. The crystal structure of a matrine derivative, 13-(methylamine-1-yl) carbodithioate matrine, C17H27N3OS2
  60. Crystal structure of bis(2-hydroxy-6-((phenylimino)methyl)phenolato-κ2N,O)copper(II), C26H20CuN2O4
  61. The crystal structure of 2-p-fluorophenyl-5-dihydroxymethyl-1,3,4-oxadiazole, C9H7FN2O3
  62. Crystal structure of dichloridobis(4-chlorophenyl-κC1)(1,10-phenanthroline-κ2N,N′)tin(IV), C24H16Cl4N2Sn
  63. Crystal structure of bis{bromido-triphenyltin(IV)}(μ2-[4,4′-bipyridine]1,1′-dioxide-κ2O:O′), C46H38Br2N2O2Sn2
  64. Crystal structure of 2-(5-chloro-quinolin-8-yloxy)-N-quinolin-8-yl-acetamide, C20H14N3O2Cl
  65. Crystal structure of bis(N-(1-(3-ethylpyrazin-2-yl)ethylidene)-3-hydroxy-2-naphthohydrazonato-κ3N,N′,O)cobalt(II) — dimethylformamide (1/1), C41H41N9O5Co
  66. Crystal structure of bis[2-(1-(3-ethylpyrazin-2-yl)ethylidene)-1-tosylhydrazin-1-ido-κ3-N,N′,O]copper(II), C30H34N8O4S2Cu
  67. Crystal structure of (2-p-tolylpyrimidine-κ2C,N)(triphenylphosphane-κP) palladium(II), C29H24ClN2PPd
  68. Halogen bonding in crystal structure of bis(1,4,7,10-tetraoxacyclododecane-κ4O,O′,O′′,O′′′)cesium triiodide, C16H32CsI3O8
  69. The synthesis and crystal structure of N-(3-cyano-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-4-(trifluoromethylsulfinyl)-1H-pyrazol-5-yl)-2-phenylacetamide, C20H10N4Cl2F6O2S
  70. The crystal structure of 4-(trifluoromethyl)nicotinic acid, C7H4F3NO2
  71. Crystal structure of 3-(2-methylbenzyl)thiazolidin-2-one, C11H13ONS
  72. The crystal structure of 2,2,2-trifluoro-1-(isoquinolin-1-yl)ethane-1,1-diol, C11H8F3NO2
  73. The crystal structure of 3-bromoisonicotinic acid, C6H4BrNO2
  74. The crystal structure of 5-nitropicolinic acid monohydrate, C6H6N2O5
  75. The crystal structure of 3-(4-hydroxybenzyl)-1,5-dioxaspiro[5.5]undecane-2,4-dione, C16H18O5
  76. Crystal structure of [[Mo3Se7(S2CNEt2)3]2(μ-Se)] ⋅ 2(C6H4Cl2), C42H68Cl4Mo6N6S12Se15
  77. Crystal structure of (E)-4-hydroxy-3-((5-phenyl-1,3,4-oxadiazol-2-yl)thio)pent-3-en-2-one, C13H12N2O3S
  78. The crystal structure of (2,3-dioxo-5,6:13,14-dibenzo-9,10-benzo-1,4,8,11-7, 11-diene-κ4N,N′,N′′,N′′′)-nickel(II), Ni(C22H14N4O2)
  79. Crystal structure of 3-(1-benzyl-2-ethyl-4-nitro-1H-imidazol-5-ylthio)-propanoic acid, C15H17N3O4S
  80. The crystal structure of dichlorobis(2-(dicyclohexylphosphino)-2′,4′,6′-tri-i-propyl-1,1′-biphenyl) palladium(II)-dichloroform, C68H100Cl8P2Pd
  81. Crystal structure and antimicrobial properties of (1,4,7,10-tetraoxacyclododecane-κ4O,O′,O′′,O′′′)cesium(I) pentaiodide, C16H32CsI5O8
Heruntergeladen am 21.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2019-0793/html
Button zum nach oben scrollen